Novel dilated cardiomyopathy associated to Calreticulin and Myo7A gene mutation in Usher syndrome

ESC Heart Fail. 2021 Jun;8(3):2310-2315. doi: 10.1002/ehf2.13260. Epub 2021 Apr 9.

Abstract

We report a novel cardiomyopathy associated to Usher syndrome and related to combined mutation of MYO7A and Calreticulin genes. A 37-year-old man with deafness and vision impairment because of retinitis pigmentosa since childhood and a MYO7A gene mutation suggesting Usher syndrome, developed a dilated cardiomyopathy with ventricular tachyarrhythmias and recurrent syncope. At magnetic resonance cardiomyopathy was characterized by left ventricular dilatation with hypo-contractility and mitral prolapse with valve regurgitation. At left ventricular endomyocardial biopsy, it was documented cardiomyocyte disconnection because of cytoskeletal disorganization of cell-to-cell contacts, including intercalated discs, and mitochondrial damage and dysfunction with significant reduction of adenosine triphosphate production in patient cultured fibroblasts. At an extensive analysis by next-generation-sequencing of 4183 genes potentially related to the cardiomyopathy a pathogenic mutation of calreticulin was found. The cardiomyopathy appeared to be functionally and electrically stabilized by a combination therapy including carvedilol and amiodarone at a follow-up of 18 months.

Keywords: CALR; Calreticulin; Cardiomyocyte disconnection; MYO7A; Usher syndrome.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Calreticulin / genetics
  • Cardiomyopathy, Dilated* / diagnosis
  • Cardiomyopathy, Dilated* / genetics
  • Child
  • DNA Mutational Analysis
  • Humans
  • Male
  • Mutation
  • Myosin VIIa
  • Myosins / genetics
  • Pedigree
  • Usher Syndromes* / diagnosis
  • Usher Syndromes* / genetics

Substances

  • Calreticulin
  • MYO7A protein, human
  • Myosin VIIa
  • Myosins